The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $18.31

Today's change0.00 0.00%
Updated May 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $18.31

Today's change0.00 0.00%
Updated May 23 4:00 PM EDT. Delayed by at least 15 minutes.

Ironwood Pharmaceuticals Inc down slightly

Ironwood Pharmaceuticals Inc closed down just (U.S.)$0.00 Tuesday to (U.S.)$18.31. Over the last five days, shares have gained 1.89% and are currently 1.24% off of the 52-week high. Shares have outperformed the S&P 500 by 42.94% during the last year.

Key company metrics

  • Open(U.S.) $17.96
  • Previous close(U.S.) $18.31
  • High(U.S.) $18.32
  • Low(U.S.) $17.83
  • Bid / Ask(U.S.) $13.14 / (U.S.) $0.00
  • YTD % change+19.75%
  • Volume663,458
  • Average volume (10-day)1,832,457
  • Average volume (1-month)1,473,138
  • Average volume (3-month)1,423,299
  • 52-week range(U.S.) $11.42 to (U.S.) $18.54
  • Beta1.48
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.83
Updated May 23 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.12%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue52876654
Total other revenue--------
Total revenue52876654
Gross profit52866654
Total cost of revenue1200
Total operating expense94949470
Selling / general / administrative56554537
Research & development34383832
Depreciation / amortization0-331
Interest expense (income), net operating--------
Unusual expense (income)2000
Other operating expenses, total219--
Operating income-42-6-28-15
Interest income (expense), net non-operating-9-10-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-53-14-33-22
Income after tax-53-14-33-22
Income tax, total--------
Net income-53-14-33-22
Total adjustments to net income--------
Net income before extra. items-53-14-33-22
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-53-14-33-22
Inc. avail. to common incl. extra. items-53-14-33-22
Diluted net income-53-14-33-22
Dilution adjustment--------
Diluted weighted average shares148146145145
Diluted EPS excluding extraordinary itemsvalue per share-0.36-0.09-0.23-0.15
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.34-0.09-0.23-0.15